![Rudy J. Emmelot](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rudy J. Emmelot
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Rudy J. Emmelot
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Biotechnology | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Rudy J. Emmelot tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
MedImmune LLC
![]() MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Chief Operating Officer | |
Abmaxis, Inc.
![]() Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA. | Pharmaceuticals: Major | Founder | |
Caltech Surveys Ltd.
![]() Caltech Surveys Ltd. Engineering & ConstructionIndustrial Services Caltech Surveys Ltd. provides mapping and data management services. Its services include well site surveys, digital surveys, digital mapping, utility surveys, construction surveys, underground facility location, and pipeline surveys. The company was founded on March 21, 1990 and is headquartered in Calgary, Canada. | Engineering & Construction | Corporate Officer/Principal | |
North Carolina State University | College/University | Corporate Officer/Principal | |
The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree | |
Agile Sciences, Inc.
![]() Agile Sciences, Inc. BiotechnologyHealth Technology Agile Sciences, Inc. develops biological compounds that disperse colonies of bio film bacteria. These compounds have applications in the medicine and agriculture industries. The company was founded by Christian Melander and John Cavanagh in 2007 and is headquartered in Durham, NC. | Biotechnology | Founder | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Chinese Academy of Sciences | College/University | Graduate Degree | |
ADAGENE INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Peking University
![]() Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Undergraduate Degree | |
The University of Chicago | College/University | Doctorate Degree | |
University of Illinois | College/University | Graduate Degree | |
University of Utrecht | College/University | Graduate Degree | |
Vtesse, Inc.
![]() Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD. | Biotechnology | Chief Executive Officer | |
REDWOOD HOLDING S.A. | Metal Fabrication | Director/Board Member | |
Polyneuron Pharmaceuticals AG
![]() Polyneuron Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Polyneuron Pharmaceuticals AG develops drugs for the treatment of autoimmune disorders. It develops drugs for the treatment of anti-MAG neuropathy disease and multifocal motor neuropathy disease. The firm also develops antibody-catch, a platform technology that enables the development of drugs for highly specific interception of autoimmune disease antibodies and focuses on autoimmune diseases of the peripheral nervous system that involve autoantibodies against carbohydrate epitopes. The company was founded by Andreas J. Steck, Beat Ernst, Pascal Hänggi and Ruben Herrendorffin in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman | |
F3 Platform Biologics, Inc.
![]() F3 Platform Biologics, Inc. BiotechnologyHealth Technology F3 Platform Biologics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and practical biotechnology for human use. It handles research, clinical development, and commercialization of new indications surrounding amifostine, a compound that has been previously approved by FDA for indications involving the prevention and treatment of side effects related to cancer treatment and radiation therapy. The company was founded on June 5, 2018 and is headquartered in Atlanta, GA. | Biotechnology | Director/Board Member | |
Janssen Biologics BV
![]() Janssen Biologics BV Pharmaceuticals: MajorHealth Technology Janssen Biologics BV manufactures, acquires and markets biopharmaceutical therapies. The firms products focus on cardiovascular and immunological disorders, and cancer. The company was founded in 1984 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
XOMA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
Omthera Pharmaceuticals, Inc.
![]() Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Chief Operating Officer | |
AbCellera Boston, Inc.
![]() AbCellera Boston, Inc. BiotechnologyHealth Technology AbCellera Boston, Inc. produces vaccines for plant, animal, and human diseases. It focuses on the discovery of novel therapeutics for autoimmune disease and pain. The company was founded by Theodore G. Clark in 2004 and is headquartered in Arlington, MA. | Biotechnology | Director/Board Member | |
The Scripps Research Institute
![]() The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
Stati Uniti | 16 |
Cina | 4 |
Paesi Bassi | 3 |
Canada | 2 |
Polonia | 2 |
Settori
Health Technology | 13 |
Consumer Services | 9 |
Industrial Services | 2 |
Commercial Services | 2 |
Producer Manufacturing | 2 |
Posizioni
Corporate Officer/Principal | 9 |
Director/Board Member | 8 |
Graduate Degree | 3 |
Undergraduate Degree | 3 |
Founder | 3 |
Contatti più connessi
Insiders | |
---|---|
Bernardus MacHielse | 11 |
Peizhi Luo | 7 |
Christian Melander | 6 |
John Kuch | 3 |
- Borsa valori
- Insiders
- Rudy J. Emmelot
- Connessioni Società